BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20398039)

  • 1. Induction concurrent chemoradiotherapy compared with induction radiotherapy for superior sulcus non-small cell lung cancer: a retrospective study.
    Li J; Dai CH; Shi SB; Bao QL; Yu LC; Wu JR
    Asia Pac J Clin Oncol; 2010 Mar; 6(1):57-65. PubMed ID: 20398039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of superior sulcus tumors: results and prognostic factors.
    Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.
    Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM
    Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study].
    van Geel AN; van der Pol C; Notenboom A; Nuyttens JJ; Eggermont AM; Surmont V; Maat AP
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1406-11. PubMed ID: 17668607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
    El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
    Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
    Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of superior sulcus tumors.
    Koizumi K; Haraguchi S; Hirata T; Hirai K; Mikami I; Yamagishi S; Okada D; Kinoshita H; Enomoto Y; Nakajima Y; Shimizu K
    Surg Today; 2005; 35(5):357-63. PubMed ID: 15864416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
    McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung carcinoma of the superior sulcus: The evolution of treatment outcomes with multimodality treatment at a single institution.
    Tagawa T; Osoegawa A; Yamazaki K; Okamoto T; Kometani T; Wataya H; Seto T; Fukuyama S; Hirai F; Sugio K; Ichinose Y
    J Surg Oncol; 2010 May; 101(6):495-9. PubMed ID: 20191604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    Rusch VW; Giroux DJ; Kraut MJ; Crowley J; Hazuka M; Winton T; Johnson DH; Shulman L; Shepherd F; Deschamps C; Livingston RB; Gandara D
    J Clin Oncol; 2007 Jan; 25(3):313-8. PubMed ID: 17235046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
    Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
    Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
    Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
    Shaikh AY; Haraf DJ; Salama JK; Salgia R; Hoffman PC; Ferguson MK; Connell PP
    Am J Clin Oncol; 2007 Jun; 30(3):258-63. PubMed ID: 17551302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
    J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.